Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol

Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol

Phytocannabinoids, found in the plant, Cannabis sativa, are an important class of natural compounds with physiological effects. These compounds can be generally divided into two classes: psychoactive and non-psychoactive. Those which do not impart psychoactivity are assumed to predominantly function...

Full description

Bibliographic Details
Main Authors:	Mohammad-Reza Ghovanloo, Sulayman D. Dib-Hajj, Samuel J. Goodchild, Peter C. Ruben, Stephen G. Waxman
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Physiology
Subjects:	cannabidiol (CBD) cannabigerol (CBG) voltage-gated sodium (Nav) channels excitability pharmacology
Online Access:	https://www.frontiersin.org/articles/10.3389/fphys.2022.1066455/full

Similar Items

Direct Quantitation of Phytocannabinoids by One-Dimensional <sup>1</sup>H qNMR and Two-Dimensional <sup>1</sup>H-<sup>1</sup>H COSY qNMR in Complex Natural Mixtures
by: Evangelos Dadiotis, et al.
Published: (2022-05-01)

Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways
by: Michael J. Viereckl, et al.
Published: (2022-06-01)

Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action
by: Seegehalli M. Anil, et al.
Published: (2022-05-01)

Could the Combination of Two Non-Psychotropic Cannabinoids Counteract Neuroinflammation? Effectiveness of Cannabidiol Associated with Cannabigerol
by: Santa Mammana, et al.
Published: (2019-11-01)

Cannabidiol and Cannabigerol Exert Antimicrobial Activity without Compromising Skin Microbiota
by: Mariana Luz-Veiga, et al.
Published: (2023-01-01)

Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes
by: Viviana di Giacomo, et al.
Published: (2020-05-01)

Neuroprotective and Neuromodulatory Effects Induced by Cannabidiol and Cannabigerol in Rat Hypo-E22 cells and Isolated Hypothalamus
by: Viviana di Giacomo, et al.
Published: (2020-01-01)

The Cytotoxic Effects of Cannabidiol and Cannabigerol on Glioblastoma Stem Cells May Mostly Involve GPR55 and TRPV1 Signalling
by: Tamara T. Lah, et al.
Published: (2022-11-01)

Safety study of cannabidiol products in healthy dogs
by: William Bookout, et al.
Published: (2024-03-01)

Differential Inhibition of Human Nav1.2 Resurgent and Persistent Sodium Currents by Cannabidiol and GS967
by: Emily R. Mason, et al.
Published: (2020-04-01)

Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo
by: Sigal Fleisher-Berkovich, et al.
Published: (2023-02-01)

Fabrication and Preliminary In Vitro Evaluation of 3D-Printed Alginate Films with Cannabidiol (CBD) and Cannabigerol (CBG) Nanoparticles for Potential Wound-Healing Applications
by: Paraskevi Kyriaki Monou, et al.
Published: (2022-08-01)

Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
by: Tamara T. Lah, et al.
Published: (2021-02-01)

A randomized, double-blind, placebo-controlled, repeated-dose pilot study of the safety, tolerability, and preliminary effects of a cannabidiol (CBD)- and cannabigerol (CBG)-based beverage powder to support recovery from delayed onset muscle soreness (DOMS)
by: Erica N. Peters, et al.
Published: (2023-12-01)

Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?
by: Leontina Elena Filipiuc, et al.
Published: (2021-11-01)

The Transcriptomic Analysis of NSC-34 Motor Neuron-Like Cells Reveals That Cannabigerol Influences Synaptic Pathways: A Comparative Study with Cannabidiol
by: Agnese Gugliandolo, et al.
Published: (2020-10-01)

In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties
by: Eduardo Perez, et al.
Published: (2022-01-01)

Evaluation of the efficacy of a cannabidiol and cannabidiolic acid rich hemp extract for pain in dogs following a tibial plateau leveling osteotomy
by: Sarah Klatzkow, et al.
Published: (2023-01-01)

The Origin and Biomedical Relevance of Cannabigerol
by: Anna Jastrząb, et al.
Published: (2022-07-01)

Cannabidiol: main mechanisms of action and therapeutic targets
by: Klaudia Kowalczyk, et al.
Published: (2023-10-01)

Spray-Dried Powder Containing Cannabigerol: A New Extemporaneous Emulgel for Topical Administration
by: Alice Picco, et al.
Published: (2023-12-01)

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
by: Gustavo Gonzalez-Cuevas, et al.
Published: (2021-10-01)

Towards Better Delivery of Cannabidiol (CBD)
by: Sophie Anne Millar, et al.
Published: (2020-08-01)

Current Challenges and Opportunities for Improved Cannabidiol Solubility
by: Khondker Rufaka Hossain, et al.
Published: (2023-09-01)

Cannabidiol, from Past to Present: a Review
by: Andra Popescu, Alexandra Dreanca, Orsolya Sarpataki, Mihai Cernea, Aurelia Jourdan, Ioan Marcus
Published: (2023-06-01)

Effects of Cannabidiol on Dugesia Dorotocephala Head Regeneration
by: Hallmon Victoria Hughes, et al.
Published: (2022-06-01)

The Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne
by: Peyravian N, et al.
Published: (2022-05-01)

Investigation of the cytotoxicity induced by cannabinoids on human ovarian carcinoma cells
by: Kartheek Sooda, et al.
Published: (2023-12-01)

Geotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001–2015
by: Albert Stuart Reece, et al.
Published: (2022-01-01)

Biological bases for a possible effect of cannabidiol in Parkinson’s disease
by: Nilson C. Ferreira-Junior, et al.

Molecular and Cellular Mechanisms of Action of Cannabidiol
by: Nadia Martinez Naya, et al.
Published: (2023-08-01)

Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study
by: Nicholas Frane, et al.
Published: (2022-08-01)

Disposition of a single oral dose of a cannabidiol medication in healthy cats
by: Tom Jukier, et al.
Published: (2023-05-01)

Cannabidiol interactions with voltage-gated sodium channels
by: Lily Goodyer Sait, et al.
Published: (2020-10-01)

Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003–2017: part 3 – spatiotemporal, multivariable and causal inferential pathfinding and exploratory analyses of prostate and ovarian cancers
by: Albert Stuart Reece, et al.
Published: (2022-03-01)

Illinois Pharmacists and Over the Counter Cannabidiol Products: A Survey on Knowledge and Educational Needs
by: Kayla Link, et al.
Published: (2020-04-01)

A urinary test procedure for identification of cannabidiol in patients undergoing medical therapy with marijuana
by: Wertlake PT, et al.
Published: (2016-02-01)

Cannabidiol (CBD) as a Promising Anti-Cancer Drug
by: Emily S. Seltzer, et al.
Published: (2020-10-01)

A Balanced Approach for Cannabidiol Use in Chronic Pain
by: Donovan A. Argueta, et al.
Published: (2020-04-01)

Parent and Caregiver Perspectives towards Cannabidiol as a Treatment for Fragile X Syndrome
by: Madison Maertens, et al.
Published: (2022-09-01)